 | • レポートコード：MRC23Q36732 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の血液凝固補助剤市場について調査・分析し、世界の血液凝固補助剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（スプレー式、粉末状）、用途別セグメント分析（病院、診療所、家庭、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Merck、WoundSeal、Baxter、CSL、Acme United、Medi-First、Grifols、Kedrion、Cramer、Celox、First Aid Onlyなどが含まれています。世界の血液凝固補助剤市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、血液凝固補助剤市場規模を推定する際に考慮しました。本レポートは、血液凝固補助剤の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、血液凝固補助剤に関するビジネス上の意思決定に役立てることを目的としています。 ・血液凝固補助剤市場の概要 - 製品の定義 - 血液凝固補助剤のタイプ別セグメント - 世界の血液凝固補助剤市場規模：タイプ別分析（スプレー式、粉末状） - 血液凝固補助剤の用途別セグメント - 世界の血液凝固補助剤市場規模：用途別分析（病院、診療所、家庭、その他） - 世界の血液凝固補助剤市場規模予測（2018年-2029年） - 血液凝固補助剤の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 血液凝固補助剤市場の競争状況およびトレンド ・血液凝固補助剤の地域別市場規模 - 北米の血液凝固補助剤市場規模（2018年-2029年） - アメリカの血液凝固補助剤市場規模（2018年-2029年） - ヨーロッパの血液凝固補助剤市場規模（2018年-2029年） - アジア太平洋の血液凝固補助剤市場規模（2018年-2029年） - 中国の血液凝固補助剤市場規模（2018年-2029年） - 日本の血液凝固補助剤市場規模（2018年-2029年） - 韓国の血液凝固補助剤市場規模（2018年-2029年） - インドの血液凝固補助剤市場規模（2018年-2029年） - オーストラリアの血液凝固補助剤市場規模（2018年-2029年） - 中南米の血液凝固補助剤市場規模（2018年-2029年） - 中東・アフリカの血液凝固補助剤市場規模（2018年-2029年） ・タイプ別セグメント：スプレー式、粉末状 - 世界の血液凝固補助剤のタイプ別販売量（2018年-2023年） - 世界の血液凝固補助剤のタイプ別売上（2018年-2023年） - 世界の血液凝固補助剤のタイプ別価格 ・用途別セグメント：病院、診療所、家庭、その他 - 世界の血液凝固補助剤の用途別販売量（2018年-2023年） - 世界の血液凝固補助剤の用途別売上（2018年-2023年） - 世界の血液凝固補助剤の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Merck、WoundSeal、Baxter、CSL、Acme United、Medi-First、Grifols、Kedrion、Cramer、Celox、First Aid Only ・産業チェーンと販売チャネルの分析 - 血液凝固補助剤産業チェーン分析 - 血液凝固補助剤の主要原材料 - 血液凝固補助剤の販売チャネル - 血液凝固補助剤のディストリビューター - 血液凝固補助剤の主要顧客 ・血液凝固補助剤市場ダイナミクス - 血液凝固補助剤の業界動向 - 血液凝固補助剤市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Blood Clotting Aids market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Blood Clotting Aids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Blood Clotting Aids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Blood Clotting Aids include Merck, WoundSeal, Baxter, CSL, Acme United, Medi-First, Grifols, Kedrion and Cramer, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Clotting Aids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Clotting Aids.
The Blood Clotting Aids market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Blood Clotting Aids market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Clotting Aids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck
WoundSeal
Baxter
CSL
Acme United
Medi-First
Grifols
Kedrion
Cramer
Celox
First Aid Only
Segment by Type
Spray
Powder
Segment by Application
Hospital
Clinic
Home
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blood Clotting Aids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blood Clotting Aids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Blood Clotting Aids Market Overview
1.1 Product Overview and Scope of Blood Clotting Aids
1.2 Blood Clotting Aids Segment by Type
1.2.1 Global Blood Clotting Aids Market Value Comparison by Type (2023-2029)
1.2.2 Spray
1.2.3 Powder
1.3 Blood Clotting Aids Segment by Application
1.3.1 Global Blood Clotting Aids Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.3.5 Others
1.4 Global Blood Clotting Aids Market Size Estimates and Forecasts
1.4.1 Global Blood Clotting Aids Revenue 2018-2029
1.4.2 Global Blood Clotting Aids Sales 2018-2029
1.4.3 Global Blood Clotting Aids Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Blood Clotting Aids Market Competition by Manufacturers
2.1 Global Blood Clotting Aids Sales Market Share by Manufacturers (2018-2023)
2.2 Global Blood Clotting Aids Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Blood Clotting Aids Average Price by Manufacturers (2018-2023)
2.4 Global Blood Clotting Aids Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Blood Clotting Aids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Clotting Aids, Product Type & Application
2.7 Blood Clotting Aids Market Competitive Situation and Trends
2.7.1 Blood Clotting Aids Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Blood Clotting Aids Players Market Share by Revenue
2.7.3 Global Blood Clotting Aids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blood Clotting Aids Retrospective Market Scenario by Region
3.1 Global Blood Clotting Aids Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Blood Clotting Aids Global Blood Clotting Aids Sales by Region: 2018-2029
3.2.1 Global Blood Clotting Aids Sales by Region: 2018-2023
3.2.2 Global Blood Clotting Aids Sales by Region: 2024-2029
3.3 Global Blood Clotting Aids Global Blood Clotting Aids Revenue by Region: 2018-2029
3.3.1 Global Blood Clotting Aids Revenue by Region: 2018-2023
3.3.2 Global Blood Clotting Aids Revenue by Region: 2024-2029
3.4 North America Blood Clotting Aids Market Facts & Figures by Country
3.4.1 North America Blood Clotting Aids Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Blood Clotting Aids Sales by Country (2018-2029)
3.4.3 North America Blood Clotting Aids Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Blood Clotting Aids Market Facts & Figures by Country
3.5.1 Europe Blood Clotting Aids Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Blood Clotting Aids Sales by Country (2018-2029)
3.5.3 Europe Blood Clotting Aids Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Clotting Aids Market Facts & Figures by Country
3.6.1 Asia Pacific Blood Clotting Aids Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Blood Clotting Aids Sales by Country (2018-2029)
3.6.3 Asia Pacific Blood Clotting Aids Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Blood Clotting Aids Market Facts & Figures by Country
3.7.1 Latin America Blood Clotting Aids Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Blood Clotting Aids Sales by Country (2018-2029)
3.7.3 Latin America Blood Clotting Aids Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Clotting Aids Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Clotting Aids Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Blood Clotting Aids Sales by Country (2018-2029)
3.8.3 Middle East and Africa Blood Clotting Aids Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blood Clotting Aids Sales by Type (2018-2029)
4.1.1 Global Blood Clotting Aids Sales by Type (2018-2023)
4.1.2 Global Blood Clotting Aids Sales by Type (2024-2029)
4.1.3 Global Blood Clotting Aids Sales Market Share by Type (2018-2029)
4.2 Global Blood Clotting Aids Revenue by Type (2018-2029)
4.2.1 Global Blood Clotting Aids Revenue by Type (2018-2023)
4.2.2 Global Blood Clotting Aids Revenue by Type (2024-2029)
4.2.3 Global Blood Clotting Aids Revenue Market Share by Type (2018-2029)
4.3 Global Blood Clotting Aids Price by Type (2018-2029)
5 Segment by Application
5.1 Global Blood Clotting Aids Sales by Application (2018-2029)
5.1.1 Global Blood Clotting Aids Sales by Application (2018-2023)
5.1.2 Global Blood Clotting Aids Sales by Application (2024-2029)
5.1.3 Global Blood Clotting Aids Sales Market Share by Application (2018-2029)
5.2 Global Blood Clotting Aids Revenue by Application (2018-2029)
5.2.1 Global Blood Clotting Aids Revenue by Application (2018-2023)
5.2.2 Global Blood Clotting Aids Revenue by Application (2024-2029)
5.2.3 Global Blood Clotting Aids Revenue Market Share by Application (2018-2029)
5.3 Global Blood Clotting Aids Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Blood Clotting Aids Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 WoundSeal
6.2.1 WoundSeal Corporation Information
6.2.2 WoundSeal Description and Business Overview
6.2.3 WoundSeal Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.2.4 WoundSeal Blood Clotting Aids Product Portfolio
6.2.5 WoundSeal Recent Developments/Updates
6.3 Baxter
6.3.1 Baxter Corporation Information
6.3.2 Baxter Description and Business Overview
6.3.3 Baxter Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Baxter Blood Clotting Aids Product Portfolio
6.3.5 Baxter Recent Developments/Updates
6.4 CSL
6.4.1 CSL Corporation Information
6.4.2 CSL Description and Business Overview
6.4.3 CSL Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CSL Blood Clotting Aids Product Portfolio
6.4.5 CSL Recent Developments/Updates
6.5 Acme United
6.5.1 Acme United Corporation Information
6.5.2 Acme United Description and Business Overview
6.5.3 Acme United Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Acme United Blood Clotting Aids Product Portfolio
6.5.5 Acme United Recent Developments/Updates
6.6 Medi-First
6.6.1 Medi-First Corporation Information
6.6.2 Medi-First Description and Business Overview
6.6.3 Medi-First Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Medi-First Blood Clotting Aids Product Portfolio
6.6.5 Medi-First Recent Developments/Updates
6.7 Grifols
6.6.1 Grifols Corporation Information
6.6.2 Grifols Description and Business Overview
6.6.3 Grifols Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Grifols Blood Clotting Aids Product Portfolio
6.7.5 Grifols Recent Developments/Updates
6.8 Kedrion
6.8.1 Kedrion Corporation Information
6.8.2 Kedrion Description and Business Overview
6.8.3 Kedrion Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Kedrion Blood Clotting Aids Product Portfolio
6.8.5 Kedrion Recent Developments/Updates
6.9 Cramer
6.9.1 Cramer Corporation Information
6.9.2 Cramer Description and Business Overview
6.9.3 Cramer Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cramer Blood Clotting Aids Product Portfolio
6.9.5 Cramer Recent Developments/Updates
6.10 Celox
6.10.1 Celox Corporation Information
6.10.2 Celox Description and Business Overview
6.10.3 Celox Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Celox Blood Clotting Aids Product Portfolio
6.10.5 Celox Recent Developments/Updates
6.11 First Aid Only
6.11.1 First Aid Only Corporation Information
6.11.2 First Aid Only Blood Clotting Aids Description and Business Overview
6.11.3 First Aid Only Blood Clotting Aids Sales, Revenue and Gross Margin (2018-2023)
6.11.4 First Aid Only Blood Clotting Aids Product Portfolio
6.11.5 First Aid Only Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Clotting Aids Industry Chain Analysis
7.2 Blood Clotting Aids Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Clotting Aids Production Mode & Process
7.4 Blood Clotting Aids Sales and Marketing
7.4.1 Blood Clotting Aids Sales Channels
7.4.2 Blood Clotting Aids Distributors
7.5 Blood Clotting Aids Customers
8 Blood Clotting Aids Market Dynamics
8.1 Blood Clotting Aids Industry Trends
8.2 Blood Clotting Aids Market Drivers
8.3 Blood Clotting Aids Market Challenges
8.4 Blood Clotting Aids Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer